The Evaluation of Efficacy and Safety of Subsequent Cisplatin and Docetaxel Regimen In The First Line Treatment of Advanced Epithelial Ovarian Cancer.

Trial Profile

The Evaluation of Efficacy and Safety of Subsequent Cisplatin and Docetaxel Regimen In The First Line Treatment of Advanced Epithelial Ovarian Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2009

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Ovarian cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Tax-Over
  • Most Recent Events

    • 14 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top